News Features Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile Michael O'Riordan October 17, 2025
News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Features Once Burned, Twice Shy, Cardiologists Ditch X for Bluesky Yael L. Maxwell November 29, 2024
News Features ‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special L.A. McKeown September 25, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Features Go Red for Women: Nearly 20 Years of Much Progress, Some Setbacks Caitlin E. Cox February 03, 2023
News Features ‘Ridiculous’ System Has Many Calling for an Interventional Cardiology Match Yael L. Maxwell October 19, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years Caitlin E. Cox December 16, 2021
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery Todd Neale July 29, 2020
News Features The Next Blaze: Pandemic Burnout Among Health Professionals Michael O'Riordan June 05, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind Todd Neale January 02, 2020